Study Says Adding Immunotherapy to Chemotherapy Improves Outcomes for Malignant Pleural Mesothelioma
Attendees at the 2023 Best of ASCO Seattle meeting were treated to exciting news from a recent Phase III mesothelioma...
from Mesothelioma.net https://ift.tt/9EiNyXr
via IFTTT
from Mesothelioma.net https://ift.tt/9EiNyXr
via IFTTT
Study Says Adding Immunotherapy to Chemotherapy Improves Outcomes for Malignant Pleural Mesothelioma
![Study Says Adding Immunotherapy to Chemotherapy Improves Outcomes for Malignant Pleural Mesothelioma]()
Reviewed by Unknown
on
September 08, 2023
Rating:
No comments: